{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:27Z","timestamp":1791052107315,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,5]],"date-time":"2014-01-05T00:00:00Z","timestamp":1388880000000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.virol.2012.10.006","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T03:42:55Z","timestamp":1354851775000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Varicella zoster vaccines and their implications for development of HSV vaccines"],"prefix":"10.1016","volume":"435","author":[{"given":"Anne A.","family":"Gershon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2012.10.006_bib1","first-page":"99","article-title":"Immune evasion mechanisms of varicella-zoster virus","volume":"17","author":"Abendroth","year":"2001","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.virol.2012.10.006_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/infdis\/137.5.531","article-title":"Selective impairment in lymphocyte reactivity to varicella-zoster antigen among untreated lymphoma patients","volume":"137","author":"Arvin","year":"1978","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib114","first-page":"189","article-title":"Varicella-zoster virus T cell tropism and the pathogenesis of skin infection","volume":"342","author":"Arvin","year":"2010","journal-title":"Curr. Top. Microbio. Immunol."},{"key":"10.1016\/j.virol.2012.10.006_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.72.3.291","article-title":"Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays","volume":"72","author":"Asano","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.virol.2012.10.006_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty year follow up of protective immunity of the Oka live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.virol.2012.10.006_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00006454-200007000-00015","article-title":"Fatal varicella-zoster virus antigen-positive giant cell arteritis of the central nervous system","volume":"19","author":"Berger","year":"2000","journal-title":"Ped. Infect. Dis. J."},{"issue":"1-2","key":"10.1016\/j.virol.2012.10.006_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2011.02.030","article-title":"Subclinical reactivation of varicella zoster virus in all stages of HIV infection","volume":"304","author":"Birlea","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.0b013e31820a0d28","article-title":"Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF","volume":"76","author":"Blumenthal","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.virol.2012.10.006_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1086\/519693","article-title":"Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection","volume":"196","author":"Bochud","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib9","doi-asserted-by":"crossref","unstructured":"Breuer, J., Grose, C., Norberg, P., Tipples, G., Schmid, D.S., 2010. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24\u201325 July 2008. J. Gen. Virol., vol. 91(Pt 4), pp. 821\u2013828.","DOI":"10.1099\/vir.0.017814-0"},{"key":"10.1016\/j.virol.2012.10.006_bib10","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.10.006_bib115","first-page":"1451","article-title":"Transmission of chickenpox in a school setting prior to the observed exanthem","volume":"143","author":"Brunell","year":"1989","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.virol.2012.10.006_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091017","article-title":"Immune responses to varicella-zoster in the aged","volume":"142","author":"Burke","year":"1982","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.virol.2012.10.006_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-immunol-030409-101335","article-title":"Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics","volume":"29","author":"Casanova","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"5797","key":"10.1016\/j.virol.2012.10.006_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1126\/science.1128346","article-title":"Herpes simplex virus encephalitis in human UNC-93B deficiency","volume":"314","author":"Casrouge","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib14","first-page":"1188","article-title":"Association of an attack of varicella and an achalasia","volume":"90","author":"Castex","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.virol.2012.10.006_bib15","first-page":"1","article-title":"Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"Centers-for-Disease-Control","year":"1996","journal-title":"Morb. Mort. Wkly. Rep."},{"key":"10.1016\/j.virol.2012.10.006_bib112","first-page":"1","article-title":"Prevention of Varicella","volume":"56","author":"Centers-for-Disease-Control","year":"2007","journal-title":"Morb. Mort. Wkly. Rep"},{"key":"10.1016\/j.virol.2012.10.006_bib113","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Centers-for-Disease-Control","year":"2007","journal-title":"MMWR"},{"issue":"11","key":"10.1016\/j.virol.2012.10.006_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.virol.2012.10.006_bib19","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s13365-011-0070-1","article-title":"Varicella zoster virus (VZV) infects and establishes latency in enteric neurons","volume":"17","author":"Chen","year":"2011","journal-title":"J. Neurovirol."},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2004.11.007","article-title":"Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster","volume":"119","author":"Chen","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/513754","article-title":"Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?","volume":"25","author":"Cinque","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib23","series-title":"Fields Virology","article-title":"Varicella-Zoster Virus: Replication, Pathogenesis, and Management","author":"Cohen","year":"2007"},{"key":"10.1016\/j.virol.2012.10.006_bib24","doi-asserted-by":"crossref","unstructured":"Cohrs, R.J., Gilden, D., 2012. Colorado Alphaherpesvirus Latency Symposium #2. J. Neurovirol.","DOI":"10.1007\/s13365-012-0129-7"},{"issue":"6","key":"10.1016\/j.virol.2012.10.006_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jmv.21173","article-title":"Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts","volume":"80","author":"Cohrs","year":"2008","journal-title":"J. Med. Virol."},{"issue":"14","key":"10.1016\/j.virol.2012.10.006_bib26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJMra0807633","article-title":"Maternal and neonatal herpes simplex virus infections","volume":"361","author":"Corey","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.10.006_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cid\/cir439","article-title":"Absence of exposure to varicella does not increase the risk of zoster","volume":"53","author":"Crumpacker","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/00365540050165893","article-title":"Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection","volume":"32","author":"De La Blanchardiere","year":"2000","journal-title":"Scand. J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.virol.2012.10.006_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.410290520","article-title":"Fatal varicella-zoster virus meningoradiculitis without skin involvement","volume":"29","author":"Dueland","year":"1991","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jemermed.2009.02.010","article-title":"Ogilvie syndrome and herpes zoster: case report and review of the literature","volume":"39","author":"Edelman","year":"2009","journal-title":"J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.10.006_bib116","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1128\/jvi.63.10.4264-4276.1989","article-title":"Varicella-zoster virus glycoproteins are phosphorylated during posttranslational maturation","volume":"63","author":"Gabel","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.10.006_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cir436","article-title":"Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)?","volume":"53","author":"Gaillat","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib35","unstructured":"Galea, S., Sweet, A., Gershon, A., LaRussa, P., Steinberg, S., Music, S., Sharrar, R., 2002. Fifth Annual Conference on Vaccine Research. Baltimore, M.D."},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2012.10.006_bib37","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/sti.2002.003848","article-title":"The potential epidemiological impact of a genital herpes vaccine for women","volume":"80","author":"Garnett","year":"2004","journal-title":"Sex Transm. Infect."},{"key":"10.1016\/j.virol.2012.10.006_bib39","series-title":"Manual of Clinical Microbiology","first-page":"1537","article-title":"Varicella-zoster virus","author":"Gershon","year":"2007"},{"key":"10.1016\/j.virol.2012.10.006_bib117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197401312900503","article-title":"Zoster immune globulin: a further assessment","volume":"290","author":"Gershon","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.10.006_bib40","unstructured":"Gershon, A., Takahashi, M., Seward, J.F., 2012. Live attenuated varicella vaccine. In: Vaccines. Plotkin S., Orenstein W., Offit P., (Eds.), 6th edition, wb Saunders, Philadelphia, Chapter 37."},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib41","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/378504","article-title":"Varicella vaccine: rare serious problems\u2014but the benefits still outweigh the risks","volume":"188","author":"Gershon","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib42","first-page":"17","article-title":"Latency of VZV in dorsal root, cranial nerve, and enteric ganglia in vaccinated children","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans. Amer. Clin. Climatol. Assoc."},{"key":"10.1016\/j.virol.2012.10.006_bib43","first-page":"359","article-title":"Perspectives on vaccines against varicella-zoster virus infections","volume":"342","author":"Gershon","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2012.10.006_bib44","first-page":"171","article-title":"Live attenuated varicella vaccine: current status and future uses","volume":"2","author":"Gershon","year":"1991","journal-title":"Semin. Ped. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/infdis\/149.2.137","article-title":"Clinical reinfection with varicella-zoster virus","volume":"149","author":"Gershon","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1984.03350030023016","article-title":"Live attenuated varicella vaccine: efficacy for children with leukemia in remission","volume":"252","author":"Gershon","year":"1984","journal-title":"J.A.M.A"},{"key":"10.1016\/j.virol.2012.10.006_bib47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/158.1.132","article-title":"Immunization of healthy adults with live attenuated varicella vaccine","volume":"158","author":"Gershon","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib48","first-page":"243","article-title":"Neurological disease produced by varicella zoster virus reactivation without rash","volume":"342","author":"Gilden","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2012.10.006_bib49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ana.410350505","article-title":"Zoster sine herpete, a clinical variant","volume":"35","author":"Gilden","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.virol.2012.10.006_bib118","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM196601272740403","article-title":"Serologic and virus-isolation studies of patients with varicella or herpes zoster infection","volume":"274","author":"Gold","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.10.006_bib50","article-title":"Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data","author":"Goldman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.10.006_bib119","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1542\/peds.70.4.550","article-title":"An outbreak of airbirne nosocomial varicella","volume":"70","author":"Gustafson","year":"1982","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"10.1016\/j.virol.2012.10.006_bib51","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1086\/522131","article-title":"Risk of herpes zoster in adults immunized with varicella vaccine","volume":"197","author":"Hambleton","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"22","key":"10.1016\/j.virol.2012.10.006_bib52","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group","volume":"325","author":"Hardy","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic- cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib54","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1542\/peds.2004-1681","article-title":"Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction","volume":"120","author":"Jean-Philippe","year":"2007","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.virol.2012.10.006_bib55","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1172\/JCI57148","article-title":"HSV-2: in pursuit of a vaccine","volume":"121","author":"Johnston","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virol.2012.10.006_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00006454-199108000-00004","article-title":"Recurrent varicella-zoster virus infections in apparently immunocompetent children","volume":"10","author":"Junker","year":"1991","journal-title":"Ped. Infect. Dis. J"},{"issue":"6","key":"10.1016\/j.virol.2012.10.006_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF03210846","article-title":"Varicella-zoster virus human ganglionic latency: a current summary","volume":"16","author":"Kennedy","year":"2011","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/j.spid.2004.09.006","article-title":"Neonatal herpes: what have we learned","volume":"16","author":"Kimberlin","year":"2005","journal-title":"Semin. Pediatr. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2012.10.006_bib59","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.108.2.e39","article-title":"Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib60","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JVI.79.5.2651-2658.2005","article-title":"Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model","volume":"79","author":"Ku","year":"2005","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.20040634","article-title":"Varicella-zoster virus transfer to skin by t cells and modulation of viral replication by epidermal cell interferon-{alpha}","volume":"200","author":"Ku","year":"2004","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2249.2011.04502.x","article-title":"Immunology in the Clinic Review Series; focus on host responses T cell responses to herpes simplex viruses","volume":"167","author":"Laing","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.virol.2012.10.006_bib120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM198002213020807","article-title":"Airborne transmission of chickenpox in a hospital","volume":"302","author":"Leclair","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.10.006_bib121","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/jvi.66.2.1016-1020.1992","article-title":"Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates","volume":"66","author":"LaRussa","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.10.006_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jis497","article-title":"A Phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults","author":"Leroux-Roels","year":"2012","journal-title":"J. Infect. Dis"},{"issue":"10","key":"10.1016\/j.virol.2012.10.006_bib65","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1086\/592452","article-title":"Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine","volume":"198","author":"Levin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib66","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1086\/378503","article-title":"Disseminated varicella infection due to vaccine (Oka) strain varicella-zoster virus in a patient with a novel deficiency in natural killer cells","volume":"188","author":"Levy","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib67","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/infdis\/153.5.840","article-title":"Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients","volume":"153","author":"Ljungman","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib68","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/135.4.659","article-title":"A longitudinal study of varicella zoster virus infections in renal transplant recipients","volume":"135","author":"Luby","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib69","first-page":"54","volume":"1979\u20132007","author":"Mahamud","year":"2012","journal-title":"Herpes zoster-related deaths in the united states: validity of death certificates and mortality rates"},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib71","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.virol.2012.10.006_bib72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jmv.10555","article-title":"Stress-induced subclinical reactivation of varicella zoster virus in astronauts","volume":"72","author":"Mehta","year":"2004","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib74","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2012.10.006_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.296.2.157","article-title":"FDA approves shingles vaccine: herpes zoster vaccine targets older adults","volume":"296","author":"Mitka","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2012.10.006_bib122","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/jvi.69.9.5236-5242.1995","article-title":"Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice","volume":"69","author":"Moffat","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.10.006_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01331-12","article-title":"Restricted VZV transcription in human trigeminal ganglia obtained early after death","author":"Ouwendijk","year":"2012","journal-title":"J. Virol"},{"issue":"2","key":"10.1016\/j.virol.2012.10.006_bib77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13365-012-0083-4","article-title":"Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash","volume":"18","author":"Ouwendijk","year":"2012","journal-title":"J. Neurovirol."},{"issue":"22","key":"10.1016\/j.virol.2012.10.006_bib78","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib79","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/infdis\/jiq066","article-title":"Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine","volume":"203","author":"Pahud","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"23","key":"10.1016\/j.virol.2012.10.006_bib80","doi-asserted-by":"crossref","first-page":"12559","DOI":"10.1128\/JVI.00939-09","article-title":"Evasion of the mucosal innate immune system by herpes simplex virus type 2","volume":"83","author":"Peng","year":"2009","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2012.10.006_bib81","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4049\/jimmunol.0900722","article-title":"Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons","volume":"184","author":"Posavad","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2012.10.006_bib82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.25.4.417","article-title":"Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds","volume":"25","author":"Preblud","year":"1984","journal-title":"Antimicrob. Agn. Chemo."},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib83","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1572-0241.2001.03808.x","article-title":"Demonstration of varicella-zoster virus infection in the muscularis propria and myenteric plexi of the colon in an HIV-positive patient with herpes zoster and small bowel pseudo-obstruction (Ogilvie's syndrome)","volume":"96","author":"Pui","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.virol.2012.10.006_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.06630-11","article-title":"Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster","author":"Quinlivan","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2012.10.006_bib85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/gut.34.3.299","article-title":"Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia","volume":"34","author":"Robertson","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.virol.2012.10.006_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","author":"Schmader","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.virol.2012.10.006_bib88","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1532-5415.1990.tb01497.x","article-title":"Are stressful life events risk factors for herpes zoster?","volume":"38","author":"Schmader","year":"1990","journal-title":"J. Am. Geriart. Soc."},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib89","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/INF.0b013e3181bbf2a0","article-title":"Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella","volume":"29","author":"Shah","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib91","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib92","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine","volume":"19","author":"Sharrar","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.10.006_bib93","unstructured":"Son, M., Shapiro, E., LaRussa, P., Neu, N., Michalik, D., Meglin, M., Bitar, W., Jurgrau, A., Flynn, P., Gershon, A., 2008. Vaccination of Children with Perinatal HIV Infection Protects against Varicella and Zoster. In: Pediatric Acdemic Societies Annual Meeting. Honolulu, HI."},{"issue":"12","key":"10.1016\/j.virol.2012.10.006_bib94","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1086\/652798","article-title":"Effectiveness of varicella vaccine in children infected with HIV","volume":"201","author":"Son","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0883073809336296","article-title":"Severe meningoencephalitis due to late reactivation of Varicella-Zoster virus in an immunocompetent child","volume":"25","author":"Spiegel","year":"2010","journal-title":"J. Child Neurol."},{"issue":"5","key":"10.1016\/j.virol.2012.10.006_bib96","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1067\/mjd.2002.119091","article-title":"Visceral zoster as the presenting feature of disseminated herpes zoster","volume":"46","author":"Stratman","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.virol.2012.10.006_bib97","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1001\/jama.1989.03430240091037","article-title":"Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infections","volume":"262","author":"Straus","year":"1989","journal-title":"JAM"},{"key":"10.1016\/j.virol.2012.10.006_bib98","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"Aug 31","key":"10.1016\/j.virol.2012.10.006_bib99","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.virol.2012.10.006_bib100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e3181acf84f","article-title":"Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002\u20132008","volume":"28","author":"Tseng","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virol.2012.10.006_bib101","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)82872-0","article-title":"Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus","volume":"116","author":"Tsolia","year":"1990","journal-title":"J. Pediatr."},{"issue":"9576","key":"10.1016\/j.virol.2012.10.006_bib102","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0140-6736(07)60848-4","article-title":"Varicella vaccine and fatal outcome in leukaemia","volume":"369","author":"Ulloa-Gutierrez","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2012.10.006_bib103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/517469","article-title":"Congenital varicella-zoster infection and Barrett's esophagus","volume":"178","author":"Ussery","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib104","unstructured":"Vazquez, M., 2012. Pediatric Academic Specialties. Boston, MA."},{"key":"10.1016\/j.virol.2012.10.006_bib105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.virol.2012.10.006_bib106","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAM"},{"issue":"9","key":"10.1016\/j.virol.2012.10.006_bib107","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1073\/pnas.0610847104","article-title":"Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia","volume":"104","author":"Verjans","year":"2007","journal-title":"Proc. Natl. Acad. Sci., USA"},{"key":"10.1016\/j.virol.2012.10.006_bib108","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/130.6.669","article-title":"Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence","volume":"130","author":"Williams","year":"1974","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2012.10.006_bib109","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/infdis\/165.1.119","article-title":"Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation","volume":"165","author":"Wilson","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.10.006_bib123","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM198312013092205","article-title":"Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus","volume":"309","author":"Weller","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"5844","key":"10.1016\/j.virol.2012.10.006_bib110","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1126\/science.1139522","article-title":"TLR3 deficiency in patients with herpes simplex encephalitis","volume":"317","author":"Zhang","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.virol.2012.10.006_bib111","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.20061792","article-title":"Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation","volume":"204","author":"Zhu","year":"2007","journal-title":"J. Exp. Med."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:18:13Z","timestamp":1758586693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682212005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0042682212005041"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.10.006","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella zoster vaccines and their implications for development of HSV vaccines","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}